Our finding is in line with the view that CBX4 is an oncogene, and the mechanism behind the decreased risk of HCC by rs2289728 might be that the SNP relieves the inhibition on CDKN2A locus by suppressing CBX4. The gene discussed is CDKN2A; the disease is hepatocellular carcinoma.